Hedgehog Pathway Cancers Clinical Trials
Pancreatic Cancer PII w/ GDC-0449, Gemcitabine, Abraxane
The emergence of new small molecules with capacity of blocking the Hedgehog signaling pathway provides a novel therapeutic approach in pancreatic adenocarcinoma treating the primary tumor, stroma, systemic metastases and pancreatic cancer stem cells by hedgehog pathway inhibition. This phase 2 clinical trial ...
more ...
Statistics : 1 Post || 180 Views
Post by hedgehog

News of Curis Hedgehog and Beyond --plus multi-targeting cancer inhibitors

